Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)	Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder	Enrolling by invitation	Not stated	2025-12-29		NCT06874894

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chung-Ang University Gwangmyeong Hospital	10
Chung-Ang University Hospital	18
Keimyung University Dongsan Medical Center	32
Korea University Ansan Hospital	11
Kosin University Gospel Hospital	5
Samsung Medical Center	207
Yuhan Corporation	14

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chung-Ang University Gwangmyeong Hospital	Gwangmyeong	South Korea	14
Chung-Ang University Hospital	Seoul	South Korea	22